Verition Fund Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-40,100
Closed -$498K 1183
2020
Q3
$498K Buy
+40,100
New +$471K 0.01% 579
2020
Q2
Sell
-42,700
Closed -$232K 1080
2020
Q1
$232K Hold
42,700
0.01% 482
2019
Q4
$386K Buy
+42,700
New +$347K 0.01% 764

Other funds holding EVH

Verition Fund Management's EVH Position: Q1 2026 in Review

Verition Fund Management sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 42,700 shares — an estimated $171K sold.

Verition Fund Management first reported a position in EVH in Q4 2016 and held it in 15 quarters. The position peaked at $1.73M in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Verition Fund Management reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 42,700 Evolent Health shares in Q1 2026, an estimated $171K.
  • Verition Fund Management first reported a position in Evolent Health in Q4 2016 and held it in 15 quarters.
  • Verition Fund Management's Evolent Health position peaked at $1.73M in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.